Mid-Career Leaders Agenda

2026 ISPE Europe Annual Conference

Built for managers implementing technologies, leading teams, and solving complex operational challenges daily.

You don't need more theory, you need solutions that work. This agenda prioritizes sessions featuring detailed case studies, implementation playbooks, and lessons learned from organizations tackling the exact challenges keeping you up at night. Every recommendation comes from peers who've been in your shoes.

Whether you're preparing your team for AI adoption, navigating regulatory complexity, or building the business case for your next initiative, these sessions deliver frameworks you can adapt and apply immediately.

This agenda includes decision-making guidance for every time slot, so you'll know exactly why each session matters to your role and goals.

Monday Schedule

TimeSessionType
0730 – 1745Registration OpenRegistration
0830 – 1200
Opening General Sessions
  • Welcome to the 2026 ISPE Europe Annual Conference
  • Leadership in a Changing World – Lars Fruergaard Jørgensen, Healthcare Denmark
  • Responding from Every Seat in Times of Unprecedented Opportunities and Challenges – Susanne Hundsbaek-Pedersen, Roche
  • A Word from the ISPE Vice President of European Operations – Thomas Zimmer
  • Reimagining Regulatory Operations in the AI Age – EMA Perspective
  • FOYA Category Winners Announcement
  • Message from the Conference Chair – David Estape, CRB Group GmbH
Strategic industry perspectives from senior leaders - valuable context for your leadership role
General Session
0945 – 1900Exhibition Area OpenNetworking
1000 – 1045Networking Break in the Exhibition AreaNetworking
1200 – 1330Networking Lunch in the Exhibition AreaMeal/Networking
1330 – 1500
Choose Your Focus:

Option A: Quality Risk Management in the Light of New European Pharma Regulations

Choose this if you're implementing ICH Q9(R1) or need to strengthen QRM maturity

Option B: Building a Sustainability Culture in Life Sciences Companies

Choose this if you're leading sustainability initiatives or building business cases

Option C: GEP & GMP Compliant Project Delivery

Choose this if you're managing capital projects or facility upgrades

Option D: Pharma Open Data Space: Turning Vision into Reality

Choose this if you're working on data strategy or cross-company collaboration

Option E: Drug Shortages Prevention

Choose this if you're responsible for supply chain resilience or manufacturing continuity
Interactive Forums
1500 – 1545Networking Break in the Exhibition AreaNetworking
1545 – 1615

KEY SESSION: Regulatory and Quality: A Case for QMS Implementation
Alex Mbonye, National Drug Authority, Uganda

Strengthen your arguments for championing quality-first approaches - gain frameworks to influence stakeholders
Regulatory and Quality
1615 – 1645

RECOMMENDED: Bridging Regulatory and Continuous Improvement Mindsets
Jessica Helbling, University of St.Gallen

Based on 60+ industry interviews - understand the real tensions between compliance and improvement and how to bridge them
Regulatory and Quality
1645 – 1715

KEY SESSION: Successful Business Cases for Sustainability Initiatives
Christian Lavarreda, Syntegon

Master lifecycle cost analysis, risk mitigation, and stakeholder engagement - apply these frameworks Monday morning
Sustainability & Substances of Concern
1715 – 1900Welcome Reception in the Exhibition AreaNetworking

Tuesday Schedule

TimeSessionType
0730 – 1730Registration OpenRegistration
0830 – 0945
Opening General Sessions
  • Day 2 Opening Remarks – Mike Martin, ISPE
  • Industrializing Biopharma: How AI and Modularization Can Close the Global Access Gap – Lars Petersen, FUJIFILM Biotechnologies
  • Keynote Presentation
Industry leadership perspectives on manufacturing transformation
General Session
0945 – 1030Networking Break in the Exhibition AreaNetworking
0945 – 1600Exhibition Area OpenNetworking
1030 – 1100

KEY SESSION: Laying the Groundwork for AI-Enabled Validation
Iwona Ziobrowska & Premkumar Iyangar, Accenture

Strategic and practical guidance on AI readiness in GxP environments - essential for preparing your organization
Digital Compliance
1100 – 1130

RECOMMENDED: Streamlining Innovation: Cloud-based Regulatory Collaboration
Nina Cauchon, PhD, Amgen Inc.

Understand how cloud platforms enable real-time multi-agency reviews - efficiency gains for industry and regulators
Regulatory and Quality
1130 – 1200

KEY SESSION: Operational Excellence Through Connected Frontlines: A Case Study
Ravi Medandravu & Scott Slavens (Eli Lilly) & Gilad Langer (Tulip)

Detailed Eli Lilly case study - actionable insights on validation, data integrity, and change management
GEP & GMP Compliant Project Delivery
1200 – 1330Networking Lunch in the Exhibition AreaMeal/Networking
1330 – 1400

RECOMMENDED: The PACMP: An Exercise in Risk Management and Communication
Stuart Finnie, Gilead Sciences

Master post-approval change management protocols - essential as PACMPs become standard regulatory tools
Regulatory and Quality
1400 – 1430

RECOMMENDED: Virtual Engineering for Pharma: From Design to Validation
Milad Jami (Novo Nordisk), Joachim Toftegaard Hansen (Aerotak) & Johan Nordling (Siemens)

See how simulation supports layout design to regulatory qualification - real case study with CFD and discrete event simulation
Pharma 4.0™ in Action
1430 – 1500

KEY SESSION: From Firefighting to Flow: How We Got Deviations in Control
Frank Seibel (Roche) & Richard Lynch (SA Partners)

Practical deviation management transformation - specific techniques for shorter closure times and fewer repeat deviations
Regulatory and Quality
1500 – 1545Networking Break in the Exhibition AreaNetworking
1545 – 1700
Closing General Sessions
  • Day 2 Conference Highlights – David Estape, CRB Group GmbH
  • Keynote Presentation
  • Keynote Presentation – Syed Abbas Yar-Khan, Eli Lilly and Company
General Session
1900 – 2300
Networking Dinner
Build relationships with peers facing similar challenges - invaluable for knowledge sharing
Networking

Wednesday Schedule

TimeSessionType
0730 – 1700Registration OpenRegistration
0830 – 1015
Opening General Sessions
  • Day 3 Opening Remarks
  • ISPE Affiliate Insights – Anders Widov, BWT Pharma & Biotech AB
  • Pharma 4.0™ Survey Results
  • Women in Pharma® Supported Presentation
Industry benchmark data to compare your organization's digital maturity
General Session
0945 – 1400Exhibition Area OpenNetworking
1015 – 1100Networking Break in the Exhibition AreaNetworking
1100 – 1130

KEY SESSION: Validating AI: From Data Integrity to Audit Readiness
Darren Geaney (Kneat) & Stefan Münch (Körber Pharma Consulting GmbH)

Practical guidance on embedding compliance in AI projects - learn what auditors actually ask
Digital Compliance
1130 – 1200

RECOMMENDED: Beyond SOPs: Compliance by Design Through Intelligent Agents
Dori Gonzalez-Acevedo (ProcellaRX) & Stephen Ferrell (Valkit.Ai)

Next-evolution thinking on GxP compliance - how intelligent agents can operationalize regulatory intent
Digital Compliance
1200 – 1230

RECOMMENDED: Explainable Compliance
Robert Hahnraths, Bayer AG

Challenge assumptions about GAMP 5 - real examples of what works and how to foster critical thinking in your team
Digital Compliance
1230 – 1400Networking Lunch in the Exhibition AreaMeal/Networking
1400 – 1630
Closing General Sessions
  • General Session
  • General Session – Tala Fakhouri, PhD, MPH, Parexel International
  • Regulatory Panel Discussion
  • Closing Remarks
Regulatory perspectives to inform your compliance strategy
General Session